Back

Interleukin-8 plasma levels correlate with changes in coronary atherosclerosis in patients with acute myocardial infarction treated with alirocumab

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (1) Inflammation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yu-Jen Wang

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

6 More presentations in this session

Presentation thumbnail
Combined effect of lipoprotein(a) and C-reactive protein on future cardiovascular outcomes after acute myocardial infarction
Doctor H. Wada (Izunokuni, JP)
Abstract Slides Video
Presentation thumbnail
Sex and age specific differences in high-sensitivity cardiac troponin T and high-sensitivity cardiac troponin I among cardiac-healthy individuals
Miss J. Elavathingal (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Impact of switching high-sensitivity cardiac troponin assays on risk stratification in suspected acute coronary syndrome
Doctor Z. Li (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Comparison of two cardiac myosin binding protein C assays for the early diagnosis and risk stratification of myocardial infarction
Doctor P. Lopez Ayala (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Diagnostic performance of a common algorithm for cardiac troponin in acute myocardial infarction
Doctor N. Thiessen (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources